12 employees
Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.
2019
$10M
from 5 investors over 5 rounds
Nanopath raised $10M on August 9, 2022
Investors: Green D Ventures, Norwest Venture Partners, Medtech Convergence Fund, Undeterred Capital and GingerBread Capital